?
z.B. 0-20
?
z.B. 0-15
?
z.B. 0-5
?
z.B. 0-3
Aktien Screener: Pharmazeutika · USA
Filter & Suche
173 Ergebnisse (2 aktive Filter)
Die Kennzahlen-Filter werden aktiviert, sobald die vollständige Liste geladen ist.
Suchergebnisse
173 Unternehmen gefunden • Seite 5 von 7
? | ? | ? | ? | ? | ? | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Immunitybio Inc | 28.0 | Arzneimittel (Biotechnologie) | USA | 9.3 Mrd. USD | - | - | 56.32 | -8.92 | ▲ 184.76% | ▲ 22.18% | - | - | - | -310.18% | ▲ 24440.35% | -226.00% | ▲ 21431.17% | -272.56% | ▲ 23590.01% | 4 / 9 | −24,62 | −2,5-fach | 22 / 100 | −9,3 / 100 | 4,30 |
 | Dianthus Therapeutics Inc. | 27.8 | Arzneimittel (Biotechnologie) | USA | 4.6 Mrd. USD | - | - | 2418.05 | 3.93 | - | - | - | - | - | -7973.33% | ▼ -1508.94% | -8739.34% | ▼ -1687.63% | -6349.36% | ▼ -526.13% | 3 / 9 | 14,36 | - | 0 / 100 | −6,3 / 100 | −4,59 |
 | Ideaya Biosciences Inc | 27.7 | Arzneimittel (Biotechnologie) | USA | 3.3 Mrd. USD | - | - | 14.00 | 2.73 | ▲ 62.11% | ▲ 28.65% | - | - | - | -51.99% | ▼ -357.72% | -72.84% | ▼ -433.42% | -33.59% | ▼ -306.31% | 4 / 9 | 13,17 | −22,3-fach | −9 / 100 | −3,8 / 100 | 13,72 |
 | Aclaris Therapeutics Inc | 27.5 | Arzneimittel (Pharmazeutisch) | USA | 0.6 Mrd. USD | - | - | 70.92 | 4.68 | ▲ 3.84% | ▲ 4.94% | - | - | - | -829.58% | ▲ 61.54% | -975.91% | ▲ 24.61% | -603.42% | ▲ 46.57% | 4 / 9 | −15,48 | - | 4 / 100 | −11,1 / 100 | 4,20 |
 | Insmed Inc | 27.5 | Arzneimittel (Biotechnologie) | USA | 24.4 Mrd. USD | - | - | 21.42 | 32.17 | ▲ 29.83% | ▲ 34.13% | - | - | - | -210.54% | ▼ -1.48% | -194.04% | ▼ -4.51% | -159.55% | ▲ 4.73% | 5 / 9 | −7,29 | −10,7-fach | 21 / 100 | −15,1 / 100 | −2,16 |
 | Editas Medicine Inc | 27.3 | Arzneimittel (Biotechnologie) | USA | 0.5 Mrd. USD | - | - | 9.64 | 4.30 | ▼ -14.89% | ▲ 7.91% | - | - | - | -395.01% | ▲ 96.23% | -245.15% | ▲ 139.10% | -409.30% | ▲ 76.89% | 4 / 9 | −29,69 | −64,8-fach | 22 / 100 | 2,8 / 100 | −5,52 |
 | Agios Pharm | 27.2 | Arzneimittel (Biotechnologie) | USA | 2.3 Mrd. USD | - | - | 23.14 | 2.22 | ▼ -23.27% | ▲ 4.75% | - | - | - | -764.01% | ▼ -774861.58% | -873.87% | ▲ 182752.68% | -698.33% | ▲ 199476.83% | 3 / 9 | 12,83 | - | 3 / 100 | −3,1 / 100 | −1,68 |
 | Axsome Therapeutics Inc | 26.9 | Arzneimittel (Pharmazeutisch) | USA | 7.5 Mrd. USD | - | - | 9.68 | 90.24 | - | - | - | - | - | -28.69% | ▲ 319.92% | -26.51% | ▲ 306.15% | -14.70% | ▲ 263.26% | 5 / 9 | −5,75 | −35,2-fach | 86 / 100 | −13,0 / 100 | −2,65 |
 | Recursion Pharmaceuticals Inc | 26.7 | Arzneimittel (Biotechnologie) | USA | 2.6 Mrd. USD | - | - | 47.41 | 2.84 | ▲ 85.36% | ▲ 49.27% | - | - | - | -863.35% | ▲ 165.01% | -867.87% | ▲ 172.49% | -506.52% | ▲ 262.61% | 4 / 9 | −1,10 | −413,4-fach | −3 / 100 | −18,5 / 100 | −3,63 |
 | ARS Pharmaceuticals, Inc | 26.6 | Arzneimittel (Biotechnologie) | USA | 0.4 Mrd. USD | - | - | 3.11 | 29.09 | ▲ 36.42% | ▲ 176.24% | - | - | - | -203.25% | ▲ 297.32% | -212.92% | ▲ 297.61% | -203.14% | ▲ 330.87% | 3 / 9 | −0,91 | −82,7-fach | 19 / 100 | −0,1 / 100 | −0,62 |
 | Supernus Pharmaceuticals Inc | 26.6 | Arzneimittel (Pharmazeutisch) | USA | 2.4 Mrd. USD | - | 129.67 | 2.93 | 2.36 | ▲ 6.68% | - | - | - | - | -5.36% | ▼ -2.71% | -5.13% | ▼ -3.45% | 6.40% | ▼ -2.19% | 5 / 9 | 5,17 | 22-fach | 44 / 100 | −5,9 / 100 | −2,43 |
 | Ocular Therapeutix Inc | 26.6 | Arzneimittel (Pharmazeutisch) | USA | 1.6 Mrd. USD | - | - | 30.76 | 3.08 | ▲ 24.39% | ▲ 11.31% | - | - | - | -513.17% | ▼ -116.19% | -521.04% | ▼ -80.03% | -418.53% | ▼ -62.07% | 4 / 9 | 3,62 | −13,7-fach | 6 / 100 | −7,6 / 100 | −2,92 |
 | Arcus Biosciences Inc | 26.6 | Arzneimittel (Biotechnologie) | USA | 2.4 Mrd. USD | - | - | 20.25 | 5.11 | ▲ 25.93% | ▲ 23.50% | - | - | - | -142.91% | ▼ -18.48% | -156.28% | ▼ -21.87% | -195.95% | ▼ -69.84% | 1 / 9 | −0,51 | −65,9-fach | 21 / 100 | 11,3 / 100 | −2,26 |
 | Celldex Therapeutics Inc | 26.5 | Arzneimittel (Biotechnologie) | USA | 2.3 Mrd. USD | - | - | 20796.30 | 3.26 | ▼ -27.36% | ▲ 34.05% | - | - | - | -17253.33% | ▼ -2895.78% | -19160.00% | ▼ -3314.63% | -14243.93% | ▼ -2361.13% | 4 / 9 | 2,23 | - | 0 / 100 | −8,2 / 100 | 0,75 |
 | Sarepta Therapeutics Inc | 26.3 | Arzneimittel (Biotechnologie) | USA | 2.0 Mrd. USD | - | - | 1.03 | 1.34 | ▲ 32.41% | ▲ 5.18% | - | - | - | -32.45% | ▲ 14.22% | -29.92% | ▲ 14.01% | -13.99% | ▲ 12.91% | 3 / 9 | −2,77 | −18,2-fach | 39 / 100 | −15,2 / 100 | −3,35 |
 | Nektar Therapeutics | 26.0 | Arzneimittel (Pharmazeutisch) | USA | 1.3 Mrd. USD | - | - | 24.51 | 1.48 | ▼ -18.43% | ▼ -18.07% | - | - | - | -297.07% | ▲ 71.30% | -236.77% | ▲ 55.61% | -377.83% | ▲ 24.00% | 3 / 9 | −41,55 | −6,0-fach | 20 / 100 | 15,9 / 100 | −1,69 |
 | Stoke Therapeutics Inc | 26.0 | Arzneimittel (Biotechnologie) | USA | 1.7 Mrd. USD | - | - | 61.77 | 4.93 | - | - | - | - | - | -3.73% | ▲ 614.71% | -11.16% | ▲ 627.93% | 24.35% | ▲ 463.98% | 5 / 9 | 5,51 | −7,9-fach | 44 / 100 | −12,5 / 100 | 2,33 |
 | Alector Inc | 25.8 | Arzneimittel (Biotechnologie) | USA | 0.3 Mrd. USD | - | - | 18.12 | -25.20 | ▼ -0.05% | ▼ -4.82% | - | - | - | -679.16% | ▼ -134.99% | -692.83% | ▼ -139.06% | -874.66% | ▼ -224.61% | 3 / 9 | −9,55 | - | 4 / 100 | 14,0 / 100 | - |
 | Taysha Gene Therapies Inc | 25.6 | Arzneimittel (Biotechnologie) | USA | 1.4 Mrd. USD | - | - | 141.03 | 5.58 | - | - | - | - | - | -1115.27% | - | -1130.65% | - | -960.07% | - | 4 / 9 | −0,50 | −59,0-fach | 3 / 100 | −4,6 / 100 | - |
 | Abeona Therapeutics Inc | 25.6 | Arzneimittel (Biotechnologie) | USA | 0.3 Mrd. USD | - | - | 10.20 | 2.03 | ▲ 14.19% | - | - | - | - | 1223.08% | ▲ 541.38% | -1536.91% | ▲ 20.24% | -1448.47% | ▼ -90.95% | 6 / 9 | −0,71 | −3,6-fach | 2 / 100 | 67,2 / 100 | 1,62 |
 | Viatris Inc | 25.5 | Arzneimittel (Pharmazeutisch) | USA | 21.6 Mrd. USD | - | 11.51 | 1.46 | 1.51 | ▲ 3.66% | ▲ 39.31% | 2.56% | ▲ 1.76% | - | -24.58% | ▼ -5.21% | -18.62% | ▼ -4.67% | 13.55% | ▼ -0.30% | 5 / 9 | 0,45 | −1,6-fach | 13 / 100 | −15,7 / 100 | −3,33 |
 | Verastem Inc | 25.3 | Arzneimittel (Biotechnologie) | USA | 1.2 Mrd. USD | - | - | 13.65 | 23.91 | ▲ 12.11% | ▲ 7.02% | - | - | - | -677.59% | ▲ 95.96% | -550.33% | ▲ 85.25% | -475.94% | ▲ 69.15% | 4 / 9 | −16,75 | −51,8-fach | 10 / 100 | −29,2 / 100 | 6,70 |
 | Ultragenyx | 25.2 | Arzneimittel (Biotechnologie) | USA | 1.7 Mrd. USD | - | - | 2.37 | -5.83 | ▲ 19.95% | ▲ 25.25% | - | - | - | -85.44% | ▲ 18.06% | -79.49% | ▲ 14.12% | -70.13% | ▲ 16.38% | 4 / 9 | −9,54 | −8,1-fach | 37 / 100 | −7,1 / 100 | −2,66 |
 | 4D Molecular Therapeutics Inc | 25.2 | Arzneimittel (Biotechnologie) | USA | 0.7 Mrd. USD | - | - | 7.76 | 1.75 | ▲ 44.32% | ▲ 19.84% | - | - | - | -164.43% | ▼ -43111.97% | -187.24% | ▼ -50374.54% | -128.65% | ▼ -37022.64% | 5 / 9 | 7,19 | - | 14 / 100 | −5,5 / 100 | - |
 | Aquestive Therapeutics Inc | 25.0 | Arzneimittel (Pharmazeutisch) | USA | 0.5 Mrd. USD | - | - | 9.38 | -8.96 | ▼ -0.58% | ▲ 8.48% | - | - | - | -188.09% | ▼ -6.12% | -156.36% | ▼ -14.15% | -118.97% | ▼ -14.12% | 2 / 9 | −7,90 | −2,3-fach | 17 / 100 | −19,5 / 100 | −2,17 |
USA